recall
saveAlembic Pharmaceuticals Limited recall (Cls II)
August 13, 2025updated 5mo ago
community read0 votes
Doxepin Hydrochloride Capsules, USP, 10 mg, 100 Capsules, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panela v 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-637-31 — Reason: CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit. — Status: Ongoing
view source ↗Data sources
last refreshed 49m ago
Found something off?
same company · ±60 days · 5
- approvalcarbamazepine ER: CARBAMAZEPINE — FDA approvalJul 25, 2025
- approvalPAROXETINE HYDROCHLORIDE: PAROXETINE HYDROCHLORIDE — FDA approvalSep 24, 2025
- approvalTIZANIDINE HYDROCHLORIDE: TIZANIDINE HYDROCHLORIDE — FDA approvalSep 24, 2025
- approvalDESIPRAMINE HYDROCHLORIDE: DESIPRAMINE HYDROCHLORIDE — FDA approvalSep 29, 2025
- recallAlembic Pharmaceuticals Limited recall (Cls II)Jun 18, 2025
🐶 often sniffed alongside
top 8- tagRecall15 co-mentions · 5 sources
- drugElyxyb6 co-mentions · 1 sources
- drugCELECOXIB6 co-mentions · 1 sources
- drugcelecoxib SR6 co-mentions · 1 sources
- drugCelebrex6 co-mentions · 1 sources
- drugfesoterodine fumarate ER6 co-mentions · 2 sources
- drugtadalafil3 co-mentions · 1 sources
- drugdoxepin hydrochloride3 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that